Literature DB >> 9074425

The relative importance of the X-linked FCP locus and beta-globin haplotypes in determining haemoglobin F levels: a study of SS patients homozygous for beta S haplotypes.

Y P Chang1, M Maier-Redelsperger, K D Smith, L Contu, R Ducroco, M de Montalembert, M Belloy, J Elion, G J Dover, R Girot.   

Abstract

Five factors have been hypothesized to influence the 20-fold variation in fetal haemoglobin (Hb F) levels in sickle cell anaemia (SS): age sex, alpha-globin gene number, beta-globin haplotype, and the X-linked F-cell production locus (FCP) that regulates the production of Hb F containing erythrocytes (F cells). We analysed the association of these factors with Hb F levels in 112 SS patients living in France who are homozygous for the three common African beta-globin haplotypes (Benin, Bantu or Central African Republic and Senegal). We found that: (1) FCP accounts for about 40% of the overall variation in Hb F levels, (2) when the FCP influence is removed, beta-globin haplotype is associated with 14% of the remaining Hb F variation, and (3) the other factors have little influence. Comparison with our previous study of SS individuals in Jamaica leads to the following conclusions: (1) the X-linked FCP locus is a major determinant of Hb F levels in SS disease, (2) factors linked to the beta-globin haplotype have only a small effect on the variation in Hb F levels, in either the homozygous or heterozygous state, and (3)approximately half of the variation in Hb F levels still remains to be explained.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9074425     DOI: 10.1046/j.1365-2141.1997.d01-2094.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

Review 1.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

2.  Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.

Authors:  Nadia Solovieff; Jacqueline N Milton; Stephen W Hartley; Richard Sherva; Paola Sebastiani; Daniel A Dworkis; Elizabeth S Klings; Lindsay A Farrer; Melanie E Garrett; Allison Ashley-Koch; Marilyn J Telen; Supan Fucharoen; Shau Yin Ha; Chi-Kong Li; David H K Chui; Clinton T Baldwin; Martin H Steinberg
Journal:  Blood       Date:  2009-12-16       Impact factor: 22.113

3.  Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study.

Authors:  Kabir O Olaniran; Andrew S Allegretti; Sophia H Zhao; Maureen M Achebe; Nwamaka D Eneanya; Ravi I Thadhani; Sagar U Nigwekar; Sahir Kalim
Journal:  J Am Soc Nephrol       Date:  2019-12-06       Impact factor: 10.121

4.  Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia.

Authors:  J C Chang; R Lu; C Lin; S M Xu; Y W Kan; S Porcu; E Carlson; M Kitamura; S Yang; L Flebbe-Rehwaldt; K M Gaensler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

5.  Modification of globin gene expression by RNA targeting strategies.

Authors:  Tong-Jian Shen; Heather Rogers; Xiaobing Yu; Felix Lin; Constance T Noguchi; Chien Ho
Journal:  Exp Hematol       Date:  2007-08       Impact factor: 3.084

6.  Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.

Authors:  Li Liu; Alexander Pertsemlidis; Liang-Hao Ding; Michael D Story; Martin H Steinberg; Paola Sebastiani; Carolyn Hoppe; Samir K Ballas; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

7.  Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil.

Authors:  Clarisse Lopes de Castro Lobo; Emilia Matos do Nascimento; Leonardo José Carvalho de Jesus; Thiago Gotelip de Freitas; Jocemir Ronaldo Lugon; Samir K Ballas
Journal:  Rev Bras Hematol Hemoter       Date:  2017-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.